{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:03:52Z","timestamp":1791201832846,"version":"4.2.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":2988,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"AstraZeneca, and Boehringer-Ingelheim"},{"name":"UCR"},{"name":"Bristol-Myers Squibb"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1111\/jth.12638","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T10:51:47Z","timestamp":1403088707000},"page":"1401-1412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["D\u2010dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation \u2013 observations from the ARISTOTLE trial"],"prefix":"10.1016","volume":"12","author":[{"given":"C.","family":"Christersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Husted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Hylek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Siegbahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12638_bb0010","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/jth.12638_bb0015","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population\u2010based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.12638_bb0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta\u2010analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12638_bb0025","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12638_bb0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12638_bb0035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jacc.2007.09.065","article-title":"Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation","volume":"51","author":"Fang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12638_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor\u2010based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1111\/jth.12638_bb0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user\u2010friendly score (HAS\u2010BLED) to assess 1\u2010year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1111\/jth.12638_bb0050","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60986-6","article-title":"Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial","volume":"380","author":"Lopes","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/jth.12638_bb0055","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-155-10-201111150-00004","article-title":"Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE\u2010LY trial","volume":"155","author":"Oldgren","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12638_bb0060","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"10.1111\/jth.12638_bb0065","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long\u2010term Anticoagulation Therapy (RE\u2010LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation"},{"key":"10.1111\/jth.12638_bb0070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2009.12.043","article-title":"Predicting left atrial thrombi in atrial fibrillation","volume":"159","author":"Wysokinski","year":"2010","journal-title":"Am Heart J"},{"key":"10.1111\/jth.12638_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0268-960X(90)90014-J","article-title":"Assessment of hypercoagulable states by measurement of activation fragments and peptides","volume":"4","author":"Boisclair","year":"1990","journal-title":"Blood Rev"},{"key":"10.1111\/jth.12638_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.0000079162.69615.0F","article-title":"Predictive value of D\u2010dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia","volume":"108","author":"Palareti","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/jth.12638_bb0085","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence\u2010based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.12638_bb0090","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.21.7752","article-title":"D\u2010dimer and prothrombin fragment\u00a01\u00a0+\u00a02 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"27","author":"Ay","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/jth.12638_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/01.STR.21.1.47","article-title":"Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation","volume":"21","author":"Gustafsson","year":"1990","journal-title":"Stroke"},{"key":"10.1111\/jth.12638_bb0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.94.3.425","article-title":"Fibrin D\u2010dimer and beta\u2010thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra\u2010low\u2010dose warfarin and aspirin","volume":"94","author":"Lip","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/jth.12638_bb0105","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/eurheartj\/ehm356","article-title":"Prediction of left atrial appendage thrombi in non\u2010valvular atrial fibrillation","volume":"28","author":"Habara","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12638_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/hrt.73.6.527","article-title":"Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment","volume":"73","author":"Lip","year":"1995","journal-title":"Br Heart J"},{"key":"10.1111\/jth.12638_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(02)00184-6","article-title":"D\u2010dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation","volume":"107","author":"Mahe","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12638_bb0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1253\/circj.CJ-11-0885","article-title":"Anticoagulation control quality affects the D\u2010dimer levels of atrial fibrillation patients","volume":"76","author":"Nakatani","year":"2012","journal-title":"Circ J"},{"key":"10.1111\/jth.12638_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1160\/TH10-06-0393","article-title":"Apixaban decreases coagulation activity in patients with acute deep vein thrombosis","volume":"105","author":"Barrett","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12638_bb0130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1160\/TH10-04-0247","article-title":"Effect of apixaban, an oral and direct factor\u00a0Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome","volume":"104","author":"Becker","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12638_bb0135","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non\u2010surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12638_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J"},{"key":"10.1111\/jth.12638_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1111\/jth.12638_bb0150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.leukres.2010.05.022","article-title":"Significance of fibrinogen, D\u2010dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia","volume":"35","author":"Kim","year":"2011","journal-title":"Leuk Res"},{"key":"10.1111\/jth.12638_bb0155","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jocn.2011.08.032","article-title":"Serum D\u2010dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage","volume":"19","author":"Chiu","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1111\/jth.12638_bb0160","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1538-7836.2012.04887.x","article-title":"Preoperative plasma D\u2010dimer predicts 1\u2010year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study","volume":"10","author":"Stender","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12638_bb0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0032-1326782","article-title":"D\u2010dimer assays in diagnosis and management of thrombotic and bleeding disorders","volume":"38","author":"Bates","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12638_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2253-12-27","article-title":"PAI\u20101 and t\u2010PA\/PAI\u20101 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass","volume":"12","author":"Ozolina","year":"2012","journal-title":"BMC Anesthesiol"},{"key":"10.1111\/jth.12638_bb0175","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12638_bb0180","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182\u00a0678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12638","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622040302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622040302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12638\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:08:32Z","timestamp":1761534512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622040302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1538783622040302"],"URL":"https:\/\/doi.org\/10.1111\/jth.12638","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u2010dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation \u2013 observations from the ARISTOTLE trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}